Floatz logo

342 assets in Glioblastoma

Therapeutic assets addressing Glioblastoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Personalized Neoantigen Dna Vaccine Supplied By Geneos Therapeutics
Glioblastoma
Washington University School of MedicineP1C (37)
Personalized Neoantigen Peptide Vaccine
Glioblastoma
Dana-Farber Cancer InstituteP1C (37)
Plasmid Encoded Il-12
Glioblastoma
Washington University School of MedicineP1C (37)
Rituximab
Glioblastoma
University of PennsylvaniaP1C (37)
Rmc-5552
Glioblastoma
Nicholas ButowskiP1C (37)
Rqnestin
Glioblastoma
Dana-Farber Cancer InstituteP1C (37)
Rsc-1255
Glioblastoma
RasCal Therapeutics, Inc.P1C (37)
tas2940
Glioblastoma
Taiho Oncology, Inc.P1C (37)
Umitrelimorgene Autodencel Human Lysosomal Associated Membrane Protein 1/Human Cytomegalovirus (Hcmv) 65 Kda Matrix Protein Mrna
Glioblastoma
University of FloridaP1C (37)
wsd0628
Glioblastoma
Mayo ClinicP1C (37)
Berubicin
Glioblastoma
WPD Pharmaceuticals Sp. z o.o.P1/2C (36)
89zr-dfo-n-suc-c9scfv
Glioblastoma
Var2 PharmaceuticalsEarly P1C (34)
89Zr-DFO-N-Suc-F8scFv
Glioblastoma
Var2 PharmaceuticalsEarly P1C (34)
Acetadote
Glioblastoma
University of Texas Southwestern Medical CenterEarly P1C (34)
Bdtx-1535
Glioblastoma
St. Joseph's Hospital and Medical Center, PhoenixEarly P1C (34)
Domvanalimab
Glioblastoma
Yale UniversityEarly P1C (34)
Lorlatinib
Glioblastoma
Nationwide Children's HospitalEarly P1C (34)
Panitumumab-Irdye800
Glioblastoma
Eben RosenthalEarly P1C (34)
Perampanel
Glioblastoma
Aarhus University HospitalEarly P1C (34)
Posaconazole
Glioblastoma
Milton S. Hershey Medical CenterEarly P1C (34)
Senicapoc
Glioblastoma
Aarhus University HospitalEarly P1C (34)
Zimberelimab
Glioblastoma
Yale UniversityEarly P1C (34)
Sabatolimab
Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1C (33)
Allogeneic Γδ T Cells
Glioblastoma
Peking University Third HospitalN/AD (30)
Autologous Nk Cells
Glioblastoma
Peking University Third HospitalN/AD (30)
Cysteine
Glioblastoma
UNC Lineberger Comprehensive Cancer CenterN/AD (30)
nkg2d car-t
Glioblastoma
UWELL BiopharmaN/AD (30)
Blood, Whole
Glioblastoma
Centre Leon BerardN/AD (28)
cm93
Glioblastoma
Crimson Biopharm Inc.P1NR ()
Crizanlizumab Tmca
Glioblastoma
Sheba Medical CenterP2NR ()
Hegfrviii-Cd3
Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACPP1NR ()
jl15003
Glioblastoma
Jecho Biopharmaceuticals Co., Ltd.P1/2NR ()
Ketoconazole
Glioblastoma
Universitas PadjadjaranEarly P1NR ()
lp-184
Glioblastoma
Starlight Therapeutics Inc.P1/2NR ()
Metabolically Armed Egfrviii Car-T Cells
Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEarly P1NR ()
ng101m
Glioblastoma
NeuGATE TheranosticsP1/2NR ()
Pep-Cmv Vaccine
Glioblastoma
Charlotte LemechP1NR ()
Personalized Dendritic Cell Vaccine Zsneo-Dc1.1
Glioblastoma
ZSky Biotech IncP2NR ()
Survivin-Loaded Dendritic Cell
Glioblastoma
Beijing Tricision Biotherapeutics IncP1NR ()
Triapine
Glioblastoma
Northwestern UniversityP1NR ()
wl276 car-t cells
Glioblastoma
Beijing Immunochina Medical Science & Technology Co., Ltd.Early P1NR ()
Showing 301 to 342 of 342 assets
PreviousPage 7 of 7Next